17-hydroxyprogesterone (17-OHP)

17-OH progesterone - welzo

17-Hydroxyprogesterone (17-OH progesterone) is a crucial steroid hormone involved in the biosynthesis of glucocorticoids, androgens, and estrogens. It plays a particularly important role in adrenal function and reproductive health. Abnormal levels of 17-OH progesterone can indicate a variety of health issues, most notably Congenital Adrenal Hyperplasia (CAH).

What is 17-OH Progesterone?

Biochemical Overview

17-OH progesterone is an endogenous progestogen and an intermediate in the biosynthesis of cortisol and androgens. It is produced primarily in:

  • The adrenal glands

  • The gonads (ovaries and testes)

It serves as a precursor molecule that undergoes enzymatic conversion by 21-hydroxylase and 11β-hydroxylase enzymes in the adrenal cortex to produce cortisol and aldosterone.

Molecular Pathway

The synthesis pathway:
Cholesterol → Pregnenolone → Progesterone → 17-OH Progesterone → 11-Deoxycortisol → Cortisol
When there's a deficiency in enzymes (e.g., 21-hydroxylase), this pathway is disrupted, leading to the accumulation of 17-OH progesterone and diverted production toward androgens.

Clinical Importance of 17-OH Progesterone

Key Functions

  • Precursor for cortisol, a vital stress hormone

  • Involved in androgen production

  • Affects sexual development and function

Role in Congenital Adrenal Hyperplasia (CAH)

The most critical clinical role of 17-OH progesterone is its elevation in CAH, a group of genetic disorders affecting adrenal steroid biosynthesis.

“Elevated 17-hydroxyprogesterone levels are a hallmark of 21-hydroxylase deficiency. Early detection through newborn screening can be life-saving.” — Dr. Mary Therese South, MD, Pediatric Endocrinologist, Mayo Clinic

17-OH Progesterone Blood Test

Why the Test is Ordered

A 17-OH progesterone blood test is primarily used to:

  • Diagnose CAH in newborns and children

  • Investigate hirsutism, infertility, or menstrual irregularities

  • Evaluate adrenal tumours or hyperplasia

  • Support hormonal investigations in reproductive or endocrine disorders

You can order a progesterone blood test here.

Normal Reference Ranges 

Group Range (ng/dL)
Newborns (preterm) 100–5000
Newborns (full-term) 100–2500
Children <100
Adult Women (follicular) 20–100
Adult Women (luteal) 100–500
Adult Men <200

Sample Collection

  • Timing: Best collected in the morning when hormone levels are highest.

  • Fasting: Usually not required.

  • Special Instructions: For women, testing should ideally occur during the follicular phase (day 3–5) of the menstrual cycle unless otherwise instructed.

Causes of Elevated 17-OH Progesterone

1. Congenital Adrenal Hyperplasia (CAH)

  • Most common cause

  • Autosomal recessive condition

  • Enzyme: 21-hydroxylase deficiency in 95% of cases

  • Leads to cortisol deficiency and androgen excess

2. Adrenal Tumours

  • Rare adrenal adenomas or carcinomas may secrete excessive 17-OH progesterone

3. Polycystic Ovary Syndrome (PCOS)

  • Mild elevations can be observed, but typically not as high as in CAH

“Differentiating PCOS from non-classic CAH is critical in women presenting with hyperandrogenic symptoms. A morning 17-OHP level >200 ng/dL warrants further evaluation with ACTH stimulation testing.” — Dr. Ricardo Azziz, Endocrinologist and PCOS expert

Causes of Low 17-OH Progesterone

Low levels are typically not concerning unless in the context of:

  • Adrenal insufficiency (Addison’s disease)

  • Hypopituitarism

  • Over-suppression from steroid therapy

17-OH Progesterone and Female Health

Menstrual Irregularities

Excess androgens due to elevated 17-OHP can disrupt ovulation, causing irregular periods, amenorrhea, or infertility.

Hirsutism and Acne

Elevated 17-OHP leads to increased production of testosterone and DHEA, contributing to male-pattern hair growth and skin issues.

“In reproductive-aged women, symptoms like hirsutism and acne, especially when paired with irregular cycles, should prompt a hormonal workup including 17-OH progesterone.” — Dr. Andrea Dunaif, MD, Reproductive Endocrinologist

Explore our range of progesterone supplements here.

17-OH Progesterone in Male Health

In men, elevated levels can indicate:

  • CAH

  • Testicular adrenal rest tumours (TARTs) in CAH patients

  • Adrenal disorders
    It may also impact fertility due to hormonal imbalances.

ACTH Stimulation Test

When 17-OHP levels are borderline or mildly elevated, an ACTH stimulation test is used to confirm or rule out non-classic CAH.

Procedure:

  • Baseline blood draw

  • Administer synthetic ACTH (cosyntropin)

  • Measure 17-OHP after 60 minutes

Interpretation:

  • A stimulated level >1500 ng/dL strongly supports non-classic CAH

Treatment Options

For CAH

  • Glucocorticoid replacement (e.g., hydrocortisone, prednisone)

  • Mineralocorticoid replacement in salt-wasting forms

  • Surgical treatment for severe virilisation

  • Regular monitoring of 17-OHP to guide therapy

For PCOS or Mild Elevation

  • Oral contraceptives

  • Anti-androgens (e.g., spironolactone)

  • Lifestyle and dietary interventions

Future of 17-OH Progesterone Testing

Advancements in genetic screening and LC-MS/MS (liquid chromatography-mass spectrometry) testing have improved accuracy.

“With better mass spectrometry-based assays, we can now distinguish between classic and non-classic CAH more reliably, even in borderline cases.” — Dr. William E. Rainey, Professor of Molecular & Integrative Physiology, University of Michigan

Summary

Aspect Details
What it is A steroid hormone involved in cortisol and androgen production
Tested for Diagnosis of CAH, PCOS, adrenal or gonadal disorders
High Levels Suggest CAH, adrenal tumours, or PCOS
Low Levels May suggest adrenal insufficiency or over-suppression by medication
Treatment Hormonal therapy, glucocorticoids, surgical intervention (if needed)
Important in Newborn screening, reproductive health, endocrine disorders

References

  1. Speiser PW, White PC. "Congenital Adrenal Hyperplasia." N Engl J Med. 2003;349(8):776-788.

  2. Azziz R. "The Evaluation and Management of Hirsutism." Obstet Gynecol. 2003;101(5 Pt 1):995-1007.

  3. New MI. "An update on congenital adrenal hyperplasia." Curr Opin Endocrinol Diabetes Obes. 2012;19(3):166–170.

  4. Trapp CM, Oberfield SE. "Diagnosis and management of congenital adrenal hyperplasia." Curr Opin Pediatr. 2012;24(4):527–533.

Share article
Get 10% off your first order

Plus get the inside scoop on our latest content and updates in our monthly newsletter.